Data from the AIM assay showed that participants in the non-saRNA group receiving mRNA vaccination only (both those convalescent and naïve for COVID-19) had greater CD4+ T cell responses than CD8+ T cell responses. The gene discussed is CD8A; the disease is COVID-19.